Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongbo Yang

Showing results (111-120 of 471) with videos related to

Pageof 48
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 31, 2018
Clinical Trajectories, Healthcare Resource Use, and Costs of Diabetic Nephropathy Among Patients with Type 2 Diabetes: A Latent Class AnalysisRuixuan Jiang, Ernest Law, Zhou Zhou, et al.
Journal of Medical Economics|July 14, 2017
Cost-effectiveness analysis of ocrelizumab versus subcutaneous interferon beta-1a for the treatment of relapsing multiple sclerosisHongbo Yang, Emilie Duchesneau, Rebekah Foster, et al.
Advances in Therapy|October 18, 2017
Treatment Patterns, Complications, and Health Care Utilization Among Endometriosis Patients Undergoing a Laparoscopy or a Hysterectomy: A Retrospective Claims AnalysisEric S Surrey, Ahmed M Soliman, Hongbo Yang, et al.
Journal of Medical Economics|July 7, 2011
Healthcare costs associated with bevacizumab and cetuximab in second-line treatment of metastatic colorectal cancerHongbo Yang, Andrew P Yu, Eric Q Wu, et al.
The Journal of Dermatological Treatment|March 18, 2020
An economic evaluation of risankizumab versus other biologic treatments of moderate to severe plaque psoriasis in JapanHidehisa Saeki, Kanako Ishii, Avani Joshi, et al.
Journal of Medical Economics|December 7, 2020
A budget impact analysis of gilteritinib for the treatment of relapsed or refractory <i>FLT3</i> <sup>mut+</sup> acute myeloid leukemia in a US health planBhavik J Pandya, Hongbo Yang, Cynthia Schmeichel, et al.
Scientific Reports|February 8, 2025
Insulin resistance surrogates are associated with all-cause mortality and cardiovascular mortality in population with metabolic syndrome: a retrospective cohort study of NHANESJinhao Liao, Linjie Wang, Lian Duan, et al.
Translational Cancer Research|February 4, 2022
A narrative review of critical factors for better efficacy of CD19 chimeric antigen receptor T cell therapy in the treatment of B cell malignanciesJia Liu, Luyao Wang, Hongbo Yang, et al.
Menopause (New York, N.Y.)|August 25, 2023
Association of menopausal vasomotor symptom severity with sleep and work impairments: a US surveyBarbara DePree, Aki Shiozawa, Deanna King, et al.
Sensors (Basel, Switzerland)|July 8, 2023
Classification and Analysis of Human Body Movement Characteristics Associated with Acrophobia Induced by Virtual Reality Scenes of HeightsXiankai Cheng, Benkun Bao, Weidong Cui, et al.
Pageof 48

Showing results (111-120 of 471) with videos related to

Sort By:
Pageof 48
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 31, 2018
Clinical Trajectories, Healthcare Resource Use, and Costs of Diabetic Nephropathy Among Patients with Type 2 Diabetes: A Latent Class AnalysisRuixuan Jiang, Ernest Law, Zhou Zhou, et al.
Journal of Medical Economics|July 14, 2017
Cost-effectiveness analysis of ocrelizumab versus subcutaneous interferon beta-1a for the treatment of relapsing multiple sclerosisHongbo Yang, Emilie Duchesneau, Rebekah Foster, et al.
Advances in Therapy|October 18, 2017
Treatment Patterns, Complications, and Health Care Utilization Among Endometriosis Patients Undergoing a Laparoscopy or a Hysterectomy: A Retrospective Claims AnalysisEric S Surrey, Ahmed M Soliman, Hongbo Yang, et al.
Journal of Medical Economics|July 7, 2011
Healthcare costs associated with bevacizumab and cetuximab in second-line treatment of metastatic colorectal cancerHongbo Yang, Andrew P Yu, Eric Q Wu, et al.
The Journal of Dermatological Treatment|March 18, 2020
An economic evaluation of risankizumab versus other biologic treatments of moderate to severe plaque psoriasis in JapanHidehisa Saeki, Kanako Ishii, Avani Joshi, et al.
Journal of Medical Economics|December 7, 2020
A budget impact analysis of gilteritinib for the treatment of relapsed or refractory <i>FLT3</i> <sup>mut+</sup> acute myeloid leukemia in a US health planBhavik J Pandya, Hongbo Yang, Cynthia Schmeichel, et al.
Scientific Reports|February 8, 2025
Insulin resistance surrogates are associated with all-cause mortality and cardiovascular mortality in population with metabolic syndrome: a retrospective cohort study of NHANESJinhao Liao, Linjie Wang, Lian Duan, et al.
Translational Cancer Research|February 4, 2022
A narrative review of critical factors for better efficacy of CD19 chimeric antigen receptor T cell therapy in the treatment of B cell malignanciesJia Liu, Luyao Wang, Hongbo Yang, et al.
Menopause (New York, N.Y.)|August 25, 2023
Association of menopausal vasomotor symptom severity with sleep and work impairments: a US surveyBarbara DePree, Aki Shiozawa, Deanna King, et al.
Sensors (Basel, Switzerland)|July 8, 2023
Classification and Analysis of Human Body Movement Characteristics Associated with Acrophobia Induced by Virtual Reality Scenes of HeightsXiankai Cheng, Benkun Bao, Weidong Cui, et al.
Pageof 48